Defects in insulin secretion and insulin action lead to multiple metabolic changes, such as hyperglycemia, increased hepatic glucose production through the overexpression of PEPCK and G6Pase, dyslipidemia and hepatic alterations in both sexes offspring of obese mothers, results corroborated in other studies [24–25]. The gene discussed is PCK2; the disease is metabolic syndrome.